- Home
- APPS vs TLRY Comparison
APPS vs TLRY Comparison
Compare APPS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APPS | TLRY |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.7M | 688.9M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | APPS | TLRY |
|---|---|---|
| Price | $8.63 | $5.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $6.25 | ★ $72.33 |
| AVG Volume (30 Days) | ★ 5.6M | 3.5M |
| Earning Date | 06-15-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.92 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $103,569,000.00 | N/A |
| Revenue This Year | $15.60 | $8.79 |
| Revenue Next Year | $11.34 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.55 | N/A |
| 52 Week Low | $2.74 | $0.36 |
| 52 Week High | $8.55 | $15.70 |
Technical Indicators
Market Signals| Indicator | APPS | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 92.12 | 42.97 |
| Support Level | $3.83 | $5.09 |
| Resistance Level | N/A | $7.01 |
| Average True Range (ATR) | 0.60 | 0.21 |
| MACD | 0.47 | 0.06 |
| Stochastic Oscillator | 91.23 | 68.95 |
Price Performance
Historical ComparisonAbout APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.